Related Experiment Videos
Studies on factors influencing human plasma alpha-MSH
G Ghanem1, J Verstegen, S De Rijcke
1L.O.C.E., Institut Bordet, Université Libre de Bruxelles, Belgium.
Anticancer Research
|November 1, 1989
Summary
Alpha-melanocyte-stimulating hormone (alpha-MSH) shows altered levels and circadian rhythms in melanoma patients. Its receptors are expressed on melanoma cells, suggesting a role in human melanoma progression.
Area of Science:
- Endocrinology
- Oncology
- Dermatology
Background:
- Alpha-melanocyte-stimulating hormone (alpha-MSH) effects are known in animals but less understood in humans.
- The physiopathological role of alpha-MSH in human melanoma remains poorly defined.
Purpose of the Study:
- To investigate the role of alpha-MSH in human melanoma.
- To measure alpha-MSH levels and receptor expression in melanoma patients and tumors.
Main Methods:
- Plasma alpha-MSH levels were measured in melanoma patients, cancer patients, and healthy adults.
- Alpha-MSH content was analyzed in human melanoma tumors.
- Alpha-MSH receptor expression on melanoma cells was assessed using radio-binding assays and tyrosinase assays.
Main Results:
- Elevated alpha-MSH levels were observed in melanoma patients' plasma.
- Alpha-MSH content was significant in melanoma metastases.
- Alpha-MSH receptor expression on melanoma cells can be modulated by melanogenesis-stimulating agents.
Conclusions:
- Alpha-MSH may play a role in human melanoma.
- Further research is warranted to elucidate the specific mechanisms and therapeutic potential of alpha-MSH in melanoma.